Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 6, Novembre 2018
Néphrologie et métabolisme
Page(s) 537 - 547
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0075
Publié en ligne 11 décembre 2018
  • Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK, (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725–1730 [CrossRef] [PubMed] [Google Scholar]
  • Czyżewski L, Sańko-Resmer J, Wyzgał J, Kurowski A, (2014) Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant 19: 576–585 [CrossRef] [PubMed] [Google Scholar]
  • Agence de la biomédecine — Le rapport annuel médical et scientifique 2016 [Google Scholar]
  • Querard AH, Le Borgne F, Dion A, Giral M, Mourad G, Garrigue V, Rostaing L, Kamar N, Loupy A, Legendre C, Morelon E, Buron F, Foucher Y, Dantan E, (2018) Propensity score-based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: toward increasing the pool of marginal donors. Am J Transplant 18: 1151–1157 [Google Scholar]
  • Klouche K, Amigues L, Massanet P, Garrigue V, Delmas S, Szwarc I, Beraud JJ, Mourad G, (2009) Outcome of renal transplant recipients admitted to an intensive care unit: a 10-year cohort study. Transplantation 87: 889–895 [CrossRef] [PubMed] [Google Scholar]
  • Canet E, Osman D, Lambert J, Guitton C, Heng AE, Argaud L, Klouche K, Mourad G, Legendre C, Timsit JF, Rondeau E, Hourmant M, Durrbach A, Glotz D, Souweine B, Schlemmer B, Azoulay E, (2011) Acute respiratory failure in kidney transplant recipients: a multicenter study. Crit Care Lond Engl 15: R91 [CrossRef] [PubMed] [Google Scholar]
  • Sadaghdar H, Chelluri L, Bowles SA, Shapiro R, (1995) Outcome of renal transplant recipients in the ICU. Chest 107: 1402–1405 [CrossRef] [PubMed] [Google Scholar]
  • Mouloudi E, Massa E, Georgiadou E, Iosifidis E, Kydona C, Sgourou K, Anagnostara E, Imvrios G, Fouzas I, Papanikolaou V, Gritsi-Gerogianni N, (2012) Course and outcome of renal transplant recipients admitted to the intensive care unit: a 20-year study. Transplant Proc 44: 2718–2720 [CrossRef] [PubMed] [Google Scholar]
  • Bige N, Zafrani L, Lambert J, Peraldi MN, Snanoudj R, Reuter D, Legendre C, Chevret S, Lemiale V, Schlemmer B, Azoulay E, Canet E, (2014) Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome. Transpl Infect Dis 16: 588–596 [CrossRef] [PubMed] [Google Scholar]
  • Canet E, Zafrani L, Azoulay É, (2016) The critically-ill kidney transplant recipient: a narrative review. Chest 149: 1546–1555 [CrossRef] [PubMed] [Google Scholar]
  • Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D, (1999) Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 14: 2332–2342 [PubMed] [Google Scholar]
  • Sarnak MJ, Jaber BL, (2000) Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58: 1758–1764 [CrossRef] [PubMed] [Google Scholar]
  • Lorent M, Giral M, Pascual M, Koller MT, Steiger J, Trébern-Launay K, Legendre C, Kreis H, Mourad G, Garrigue V, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Golshayan D, Foucher Y, (2016) Mortality prediction after the first year of kidney transplantation: an observational study on two European cohorts. PloS One 11: e0155278 [CrossRef] [PubMed] [Google Scholar]
  • Metalidis C, Kuypers D, (2011) Immunosuppressive therapy after kidney transplantation: current and new strategies. Minerva Urol Nefrol 63: 1–19 [PubMed] [Google Scholar]
  • Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D, (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342: 605–612 [CrossRef] [PubMed] [Google Scholar]
  • Fishman JA, (2007) Infection in solid-organ transplant recipients. N Engl J Med 357: 2601–2614 [CrossRef] [PubMed] [Google Scholar]
  • Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ, (2010) Reduction in cardiovascular death after kidney transplantation. Transplantation 89: 851–857 [CrossRef] [PubMed] [Google Scholar]
  • Jeloka TK, Ross H, Smith R, Huang M, Fenton S, Cattran D, Schiff J, Cardella C, Cole E, (2007) Renal transplant outcome in high-cardiovascular risk recipients. Clin Transplant 21: 609–614 [CrossRef] [PubMed] [Google Scholar]
  • Dharnidharka VR, Schnitzler MA, Chen J, Brennan DC, Axelrod D, Segev DL, Schechtman KB, Zheng J, Lentine KL, (2016) Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study. Transpl Int 29: 1226–1236 [Google Scholar]
  • Kalil AC, Syed A, Rupp ME, Chambers H, Vargas L, Maskin A, Miles CD, Langnas A, Florescu DF, (2015) Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensityadjusted study. Clin Infect Dis 60: 216–222 [CrossRef] [PubMed] [Google Scholar]
  • Malinis MF, Mawhorter SD, Jain A, Shrestha NK, Avery RK, van Duin D, (2012) Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients. Transplantation 93: 1045–1050 [CrossRef] [PubMed] [Google Scholar]
  • Schachtner T, Stein M, Reinke P, (2018) Sepsis after renal transplantation: clinical, immunological, and microbiological risk factors. Transpl Infect Dis (doi: 10.1111/tid.12695. Epub 2017 May 9) [Google Scholar]
  • Bafi AT, Tomotani DYV, de Freitas FGR, (2017) Sepsis in solidorgan transplant patients. Shock 47: 12–16 [Google Scholar]
  • Mourad G, Serre JE, Alméras C, Basel O, Garrigue V, Pernin V, Le Quintrec M, (2016) Infectious and neoplasic complications after kidney transplantation. Nephrol Ther 12: 468–487 [CrossRef] [PubMed] [Google Scholar]
  • Helanterä I, Schachtner T, Hinrichs C, Salmela K, Kyllönen L, Koskinen P, Lautenschlager I, Reinke P, (2014) Current characteristics and outcome of cytomegalovirus infections after kidney transplantation. Transpl Infect Dis 16: 568–577 [CrossRef] [PubMed] [Google Scholar]
  • Wan S, Roberts MA, Mount P, (2016) Normal saline versus lower-chloride solutions for kidney transplantation. Cochrane Database Syst Rev 8: CD010741 [Google Scholar]
  • Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW, (2018) Balanced crystalloids versus saline in critically-ill adults. N Engl J Med 378: 829–839 [CrossRef] [PubMed] [Google Scholar]
  • Mårtensson J, Bellomo R, (2015) Are all fluids bad for the kidney. Curr Opin Crit Care 21: 292–301 [CrossRef] [PubMed] [Google Scholar]
  • Shih CJ, Tarng DC, Yang WC, Yang CY, (2014) Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia. Singapore Med J 55: 372–377 [CrossRef] [PubMed] [Google Scholar]
  • Tu G, Ju M, Zheng Y, Zhu D, Xu M, Rong R, Zhu T, Luo Z, (2014) An interdisciplinary approach for renal transplant recipients with severe pneumonia: a single ICU experience. Intensive Care Med 40: 914–915 [CrossRef] [PubMed] [Google Scholar]
  • Sun Q, Liu ZH, Chen J, Ji S, Tang Z, Cheng Z, Ji D, Li LS, (2006) An aggressive systematic strategy for acute respiratory distress syndrome caused by severe pneumonia after renal transplantation. Transpl Int 19: 110–116 [Google Scholar]
  • Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR, van de Louw A, Hemelaar P, Lemiale V, Taccone FS, Martin Loeches I, Meyhoff TS, Salluh J, Schellongowski P, Rusinova K, Terzi N, Mehta S, Antonelli M, Kouatchet A, Barratt-Due A, Valkonen M, Landburg PP, Bruneel F, Bukan RB, Pène F, Metaxa V, Moreau AS, Souppart V, Burghi G, Girault C, Silva UVA, Montini L, Barbier F, Nielsen LB, Gaborit B, Mokart D, Chevret S, Efraim investigators and the Nine-I study group, (2017) Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 43: 1808–1819 [CrossRef] [PubMed] [Google Scholar]
  • Godet C, Elsendoorn A, Roblot F, (2012) Benefit of CT scanning for assessing pulmonary disease in the immunodepressed patient. Diagn Interv Imaging 93: 425–430 [Google Scholar]
  • Reichenberger F, Dickenmann M, Binet I, Solèr M, Bolliger C, Steiger J, Brunner F, Thiel G, Tamm M, (2001) Diagnostic yield of bronchoalveolar lavage following renal transplantation. Transpl Infect Dis 3: 2–7 [CrossRef] [PubMed] [Google Scholar]
  • Sileri P, Pursell KJ, Coady NT, Giacomoni A, Berliti S, Tzoracoleftherakis E, Testa G, Benedetti E, (2002) A standardized protocol for the treatment of severe pneumonia in kidney transplant recipients. Clin Transplant 16: 450–454 [CrossRef] [PubMed] [Google Scholar]
  • Amigues L, Klouche K, Massanet P, Gaillard N, Garrigue V, Beraud JJ, Mourad G, (2005) Sirolimus-associated acute respiratory distress syndrome in a renal transplant recipient. Transplant Proc 37: 2830–2831 [CrossRef] [PubMed] [Google Scholar]
  • Ulas A, Kaplan S, Zeyneloglu P, Torgay A, Pirat A, Haberal M, (2015) Acute respiratory failure in renal transplant recipients: a single intensive care unit experience. Exp Clin Transplant 13: 44–47 [PubMed] [Google Scholar]
  • Tu G, He H, Yin K, Ju M, Zheng Y, Zhu D, Luo Z, (2017) Highflow nasal cannula versus noninvasive ventilation for treatment of acute hypoxemic respiratory failure in renal transplant recipients. Transplant Proc 49: 1325–1330 [CrossRef] [PubMed] [Google Scholar]
  • Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP, (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344: 481–487 [CrossRef] [PubMed] [Google Scholar]
  • Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E, Nyunga M, Girault C, Perez P, Guitton C, Ekpe K, Kouatchet A, Théodose I, Benoit D, Canet E, Barbier F, Rabbat A, Bruneel F, Vincent F, Klouche K, Loay K, Mariotte E, Bouadma L, Moreau AS, Seguin A, Meert AP, Reignier J, Papazian L, Mehzari I, Cohen Y, Schenck M, Hamidfar R, Darmon M, Demoule A, Chevret S, Azoulay E; Groupe de recherche en réanimation respiratoire du patient d’onco-hématologie (GRRR-OH), (2015) Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 314: 1711–1719 [CrossRef] [PubMed] [Google Scholar]
  • Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JCM, Brochard L, Robert R; FLORALI Study Group, REVA Network, (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372: 2185–2196 [CrossRef] [PubMed] [Google Scholar]
  • Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, Demoule A, Ricard JD, Coudroy R, Robert R, Mercat A, Brochard L, Thille AW; REVA network, (2016) Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post hoc analysis of a randomised trial. Lancet Respir Med 4: 646–652 [Google Scholar]
  • Lemiale V, Resche-Rigon M, Mokart D, Pène F, Argaud L, Mayaux J, Guitton C, Rabbat A, Girault C, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Seguin A, Klouche K, Colin G, Kontar L, Perez P, Meert AP, Benoit DD, Papazian L, Demoule A, Chevret S, Azoulay E, (2017) High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de recherche respiratoire en réanimation onco-hématologique study. Crit Care Med 45: e274–e280 [CrossRef] [PubMed] [Google Scholar]
  • Huang HB, Peng JM, Weng L, Liu GY, Du B, (2018) High-flow oxygen therapy in immunocompromised patients with acute respiratory failure: a review and meta-analysis. J Crit Care 43: 300–305 [Google Scholar]
  • Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Berrahil-Meksen L, Louis G, Constantin JM, Mayaux J, Wallet F, Kouatchet A, Peigne V, Theodose I, Perez P, Girault C, Jaber S, Oziel J, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Darmon M, Chevret S, Demoule A, (2018) Effect of High-flow nasal oxygen vs. standard oxygen therapy on 28-Day mortality in immunocompromised patients with acute respiratory failure: The HIGH Randomized Clinical Trial. JAMA 320: 2099–2107 [CrossRef] [PubMed] [Google Scholar]
  • Brunot V, Pernin V, Chartier C, Garrigue V, Vetromile F, Szwarc I, Delmas S, Portalès P, Basset D, Mourad G, (2012) An epidemic of pneumocystis jiroveci pneumonia in a renal transplantation center: role of T-cell lymphopenia. Transplant Proc 44: 2818–2820 [CrossRef] [PubMed] [Google Scholar]
  • Zhang P, Ye Q, Wan Q, Zhou J, (2016) Mortality predictors in recipients developing acute respiratory distress syndrome due to pneumonia after kidney transplantation. Ren Fail 38: 1082–1088 [CrossRef] [PubMed] [Google Scholar]
  • Shorr AF, Abbott KC, Agadoa LY, (2003) Acute respiratory distress syndrome after kidney transplantation: epidemiology, risk factors, and outcomes. Crit Care Med 31: 1325–1330 [CrossRef] [PubMed] [Google Scholar]
  • Cortegiani A, Madotto F, Gregoretti C, Bellani G, Laffey JG, Pham T, Van Haren F, Giarratano A, Antonelli M, Pesenti A, Grasselli G; LUNG SAFE Investigators and the ESICM Trials Group, (2018) Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database. Crit Care Lond Engl 22: 157 [CrossRef] [Google Scholar]
  • Freitas FGR, Lombardi F, Pacheco ES, de Sandes-Freitas TV, Viana LA, Junior HTS, Medina-Pestana JO, Bafi AT, Machado FR, (2018) Clinical features of kidney transplant recipients admitted to the intensive care unit. Prog Transplant Aliso Viejo Calif 28: 56–62 [CrossRef] [Google Scholar]
  • Charbonney E, Saudan P, Triverio PA, Quinn K, Mentha G, Martin PY, (2009) Prognosis of acute kidney injury requiring renal replacement therapy in solid organ transplanted patients. Transpl Int 22: 1058–1063 [Google Scholar]
  • Garg N, Rennke HG, Pavlakis M, Zandi-Nejad K, (2018) De novo thrombotic microangiopathy after kidney transplantation. Transplant Rev Orlando Fla 32: 58–68 [CrossRef] [Google Scholar]
  • Lanot E, Bouvier N, Chatelet V, Dina J, Béchade C, Ficheux M, Henri P, Lobbedez T, Hurault de Ligny B, (2016) BK virus infections in kidney transplantation. Nephrol Ther 12: 76–85 [CrossRef] [PubMed] [Google Scholar]
  • Wright AJ, Fishman JA, (2014) Central nervous system syndromes in solid organ transplant recipients. Clin Infect Dis 59: 1001–1011 [CrossRef] [PubMed] [Google Scholar]
  • Piotrowski PC, Lutkowska A, Tsibulski A, Karczewski M, Jagodziński PP, (2017) Neurologic complications in kidney transplant recipients. Folia Neuropathol 55: 86–109 [CrossRef] [PubMed] [Google Scholar]
  • Coussement J, Lebeaux D, van Delden C, Guillot H, Freund R, Marbus S, Melica G, Van Wijngaerden E, Douvry B, Van Laecke S, Vuotto F, Tricot L, Fernández-Ruiz M, Dantal J, Hirzel C, Jais JP, Rodriguez-Nava V, Lortholary O, Jacobs F; European Study Group for Nocardia in Solid Organ Transplantation, (2016) Nocardia infection in solid organ transplant recipients: a multicenter European case-control study. Clin Infect Dis 63: 338–345 [CrossRef] [PubMed] [Google Scholar]
  • Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre-Cisneros J, Martín-Dávila P, Noblejas A, Len O, García-Reyne A, Del Pozo JL, Carratalà J, (2012) Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study. Clin Infect Dis 54: 355–361 [CrossRef] [PubMed] [Google Scholar]
  • Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner PH, Swinnen JL, Woodle ES, Bromberg JS, (1999) Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 68: 1517–1525 [CrossRef] [PubMed] [Google Scholar]
  • Donnelly JP, Locke JE, MacLennan PA, McGwin G, Mannon RB, Safford MM, Baddley JW, Muntner P, Wang HE, (2016) Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis. Clin Infect Dis 63: 186–194 [CrossRef] [PubMed] [Google Scholar]
  • Arulkumaran N, West S, Chan K, Templeton M, Taube D, Brett SJ, (2012) Long-term renal function and survival of renal transplant recipients admitted to the intensive care unit. Clin Transplant 26: E24–E31 [CrossRef] [PubMed] [Google Scholar]
  • Badin J, Longuet H, Guillon A, Barbet C, Halimi JM, Lebranchu Y, Perrotin D, Buchler M, (2012) Renal function of renal transplantation patients after hospitalization in an intensive care unit. Transplant Proc 44: 2792–2794 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.